NCT00058045View on ClinicalTrials.gov

Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

November 30, 2003

Conditions
Lymphoma
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

recombinant human stem cell factor

Trial Locations (2)

43210

Arthur G. James Cancer Hospital - Ohio State University, Columbus

14263-0001

Roswell Park Cancer Institute, Buffalo

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00058045 - Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer | Biotech Hunter | Biotech Hunter